MPLT earnings date and last-quarter result: next report 2026-09-18, last quarter miss, P/E -7.71. Updated 2026-07-23.
MapLight Therapeutics (MPLT) Research Hub
MapLight Therapeutics (MPLT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 7.66 USD (-3.89%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -7.71, market cap 0.03B. This hub links to the full technical, earnings and options research available for MPLT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 7.66 USD (-3.89%) |
| 52-week range | 7.46 USD – 39.91 USD |
| Trend regime | Range |
| 14-day RSI | 22.6 (Oversold) |
| Trailing P/E | -7.71 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-18 |
Available research for MPLT
Covered Call on MPLT: how it works, illustrative setup around the real 7.66 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MPLT: how it works, illustrative setup around the real 7.66 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MPLT: how it works, illustrative setup around the real 7.66 USD price, max profit/loss, breakeven and when to use it. Educational.
MPLT technical analysis: range, last 7.66 USD, RSI 22.6, 52w range 7.46 USD–39.91 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MPLT in?
MapLight Therapeutics (MPLT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MPLT in an uptrend or downtrend?
As of 2026-10-26, MPLT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MPLT's trailing P/E ratio?
MPLT's trailing P/E is -7.71, with a market cap of 0.03B. See the earnings research page for full valuation detail.
When does MPLT next report earnings?
MPLT is next scheduled to report earnings on 2026-09-18.